Your browser doesn't support javascript.
loading
Measurement of HE4 six months after first-line treatment as optimal time in identifying patients at high risk of progression advanced ovarian cancer.
Kotowicz, Beata U; Fuksiewicz, Malgorzata; Bidzinski, Mariusz; Berezowska, Alicja; Sobiczewski, Piotr; Kowalska, Maria M.
Afiliação
  • Kotowicz BU; Independent laboratory of Tumor Biomarkers and Cytokines, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. beata.kotowicz@pib-nio.pl.
  • Fuksiewicz M; Independent laboratory of Tumor Biomarkers and Cytokines, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Bidzinski M; Department of Gynecologic Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Berezowska A; Independent laboratory of Tumor Biomarkers and Cytokines, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Sobiczewski P; Department of Gynecologic Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Kowalska MM; Independent laboratory of Tumor Biomarkers and Cytokines, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Ginekol Pol ; 93(11): 910-915, 2022.
Article em En | MEDLINE | ID: mdl-36621970

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteína 2 do Domínio Central WAP de Quatro Dissulfetos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Ginekol Pol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteína 2 do Domínio Central WAP de Quatro Dissulfetos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Ginekol Pol Ano de publicação: 2022 Tipo de documento: Article